The MOTION study: Two‐year results of a real‐world randomized controlled trial of the mild® procedure for treatment of lumbar spinal stenosis

Author:

Deer Timothy R.1ORCID,Chafin Timothy B.2ORCID,Costandi Shrif J.3ORCID,Qu Huaguang4,Kim Christopher1,Jassal Navdeep5,Patel Kiran6,Calodney Aaron7ORCID

Affiliation:

1. The Spine & Nerve Centers of the Virginias Charleston West Virginia USA

2. Vidant Roanoke‐Chowan Hospital Ahoskie North Carolina USA

3. Cleveland Clinic Cleveland Ohio USA

4. Pennsylvania Pain& Spine Institute Chalfont Pennsylvania USA

5. Excel Pain and Spine Lakeland Florida USA

6. The Spine & Pain Institute of New York New Hyde Park New York USA

7. Precision Spine Care Tyler Texas USA

Abstract

AbstractObjectiveThe MOTION study is designed to measure the impact of percutaneous image‐guided lumbar decompression as a first‐line therapy on patients otherwise receiving real‐world conventional medical management for lumbar spinal stenosis with neurogenic claudication secondary to hypertrophic ligamentum flavum. This prospective, multicenter randomized controlled trial uses objective and patient‐reported outcome measures to compare the combination of the mild® percutaneous treatment and nonsurgical conventional medical management (CMM) to CMM‐Alone.MethodsTest group patients received the mild procedure after study enrollment. Test and control groups were allowed conventional conservative therapies and low‐risk interventional therapies as recommended by their physicians. Subjective outcomes included the Oswestry Disability Index, Numeric Pain Rating Scale, and Zurich Claudication Questionnaire. Objective outcomes included a validated Walking Tolerance Test, the rate of subsequent lumbar spine interventions, and safety data.ResultsTwo‐year follow‐up included 64 mild + CMM and 67 CMM‐Alone patients. All outcome measures showed significant improvement from baseline for mild + CMM, whereas the majority of CMM‐Alone patients had elected to receive mild treatment or other lumbar spine interventions by 2 years, precluding valid 2‐year between‐group comparisons. Neither group reported any device‐ or procedure‐related adverse events.ConclusionsThe durability of mild + CMM for this patient population was demonstrated for all efficacy outcomes through 2 years. Improvements in walking time from baseline to 2 years for patients treated with mild + CMM were significant and substantial. The lack of reported device or procedure‐related adverse events reinforces the strong safety profile of the mild procedure. These results provide support for early interventional treatment of symptomatic LSS with the mild procedure.

Publisher

Wiley

Subject

Anesthesiology and Pain Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3